Phase I Study to Determine the Safety and Tolerability of the Oral Microtubule Destabilizer BAL 101553 in Combination with Standard Radiation in Patients with MGMT Promoter Unmethylated Newly Diagnosed Glioblastoma

Grant

Date/time Interval

  • September 24, 2017 - April 30, 2020
  • Total Award Amount

  • 18000.00
  • Direct Costs

  • 9270.00
  • Sponsor Award Id

  • ABTC1601
  • Contributor

  • Fathallah-Shaykh M.D., Ph.D., Hassan   Investigator  
  • Han, Xiaosi   Investigator  
  • Nabors M.D., Louis   Principal Investigator